Alembic Pharmaceuticals Dividend & Ex-dividend History
Alembic Pharmaceuticals dividend history & ex-dividend dates. Alembic Pharmaceuticals (APLLTD) has paid dividends for 10 years, annual, with a current yield of 1.14% and an average yield of 1.24% (100.0% consistency). The last dividend was ₹12.0 per share (2026-March, 1.16% yield), peak yield 2.13%. For the full company profile including live price and ratios, see Alembic Pharmaceuticals share price today.
Dividend Data Export
Dividend Summary
Alembic Pharmaceuticals Dividend Per Share & Yield History
APLLTD annual dividend per share (DPS) and dividend yield over 10 years. See APLLTD P/B ratio history to compare market price against book value per share.
Alembic Pharmaceuticals Dividend Payment History
APLLTD ex-dividend dates, dividend per share, yield and payment type — 10 records. View APLLTD price range for the annual high/low range and current price position.
| Year | Period | Dividend per Share | Dividend Yield | Payment Type |
|---|---|---|---|---|
| 2026 | March | ₹12.00 | 1.16% | Annual |
| 2025 | March | ₹11.00 | 1.66% | Annual |
| 2024 | March | ₹11.00 | 1.18% | Annual |
| 2023 | March | ₹8.00 | 0.81% | Annual |
| 2022 | March | ₹10.00 | 2.13% | Annual |
| 2021 | March | ₹14.00 | 1.89% | Annual |
| 2020 | March | ₹10.00 | 1.04% | Annual |
| 2019 | March | ₹5.50 | 1.03% | Annual |
| 2018 | March | ₹4.00 | 0.74% | Annual |
| 2017 | March | ₹4.00 | 0.73% | Annual |
Frequently Asked Questions
Alembic Pharmaceuticals last paid a dividend of ₹12.0 with a yield of 1.16%. The company typically pays dividends annual.
Alembic Pharmaceuticals has an average dividend yield of 1.24% based on historical data. The highest yield recorded was 2.13% and the lowest was 0.73%.
Alembic Pharmaceuticals typically pays dividends annual. The company has maintained a consistent payment frequency.
Alembic Pharmaceuticals has paid dividends with 100.0% consistency over 10 years. The company has paid dividends in 10 out of 10 years tracked. Consider this alongside your investment goals and risk tolerance.